计算机科学
药物发现
计算生物学
人工智能
药物开发
领域(数学)
机器学习
生物信息学
生物
药品
药理学
数学
纯数学
作者
Luís Perpétuo,Julie Klein,Rita M. Ferreira,Sofia de Morais Guedes,Francisco Manuel Lemos Amado,Adelino Ferreira Leite-Moreira,Artur M. S. Silva,Visith Thongboonkerd,Rui Miguel Pinheiro Vitorino
标识
DOI:10.1080/14789450.2021.1962303
摘要
INTRODUCTION: Peptidomics is an emerging field of omics sciences using advanced isolation, analysis, and computational techniques that enable qualitative and quantitative analyses of various peptides in biological samples. Peptides can act as useful biomarkers and as therapeutic molecules for diseases. AREAS COVERED: The use of therapeutic peptides can be predicted quickly and efficiently using data-driven computational methods, particularly artificial intelligence (AI) approach. Various AI approaches are useful for peptide-based drug discovery, such as support vector machine, random forest, extremely randomized trees, and other more recently developed deep learning methods. AI methods are relatively new to the development of peptide-based therapies, but these techniques already become essential tools in protein science by dissecting novel therapeutic peptides and their functions (Figure 1). EXPERT OPINION: Researchers have shown that AI models can facilitate the development of peptidomics and selective peptide therapies in the field of peptide science. Biopeptide prediction is important for the discovery and development of successful peptide-based drugs. Due to their ability to predict therapeutic roles based on sequence details, many AI-dependent prediction tools have been developed (Figure 1).
科研通智能强力驱动
Strongly Powered by AbleSci AI